Sort
48,018 grants matching “immunotherapy”
BIOLOGY AND TRANSPLANTATION OF THE HUMAN STEM CELL
$1,550,643University Of Minnesota Twin Cities · P01 · FY2004 · CA
THERAPY OF LYMPHOMA/LEUKEMIA WITH MONOCLONAL ANTIBODIES
$1,550,268Fred Hutchinson Cancer Research Center · P01 · FY2000 · CA
TARGETED IMMUNOTHERAPY OF BREAST CANCER BRAIN METASTASIS BY CHIMERIC ANTIGEN RECEPTOR MACROPHAGE
$1,549,999Wake Forest University Health Sciences · · FY2022 · Defense Health Agency
Active Immune Therapy and HAART for HIV-1 Infection
$1,549,799University Of Pennsylvania · P01 · FY2003 · AI
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
$1,549,397Charles Bix Shoemaker · Tufts University Boston · R01 · FY2025 · AI
Neutralizing Botulinum Neurotoxin with Human Antibodies
$1,548,781Rae Lyn Burke · Sri International · U01 · FY2007 · AI
Metabolic regulation of T cell effector function and anti-tumor immunotherapy
$1,548,567Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies
$1,548,129Anish Thomas · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Comprehensive dissection of the CLL genome & phenome to improve patient outcomes
$1,546,492Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2024 · CA
ETIB Clinical Research Core
$1,545,783Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2020 · CA
IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine
$1,545,717Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
MIAMI ADULT AIDS CLINICAL TRIALS GROUP, AACTG
$1,543,843University Of Miami School Of Medicine · U01 · FY2000 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,543,278Duke University · U01 · FY2004 · AI
Adoptive Cell Transfer Immunotherapy of Cancer
$1,543,070Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
ADULT AIDS CLINICAL TRIALS UNIT (ACTU)
$1,542,920University Of Southern California · U01 · FY2002 · AI
PRIMAVO: Interactive exploration of cancer patient precision immune monitoring data in clinical trials
$1,542,450Zeynep Hulya Gumus · Icahn School Of Medicine At Mount Sinai · R33 · FY2021 · CA
Immunological Strategies to Modulate SIV Rebound Following ART Interruption
$1,541,832Michael R Betts · University Of Pennsylvania · P01 · FY2019 · AI
Development of new antibody-based cancer therapies
$1,541,067Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
MIAMI ADULT AIDS CLINICAL TRIALS GROUP, AACTG
$1,540,981University Of Miami School Of Medicine · U01 · FY2001 · AI
Area A: Development of genetically tractable, driver gene-syngeneic brain tumor models for pre-clinical adoptive TCR-T therapy
$1,540,837Qijing Li · Duke University · R33 · FY2017 · CA
Preclinical drug development in pancreatic cancer
$1,539,190Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Mechanisms of Esophageal Carcinogenesis
$1,538,540Anil K Rustgi · Columbia University Health Sciences · P01 · FY2022 · CA
NOVEL IMMUNE BASED THERAPIES FOR MULTIPLE MYELOMA
$1,538,491Dana-Farber Cancer Institute · P01 · FY2002 · CA
COLUMBIA-ADARC AIDS CLINICAL TRIALS UNIT
$1,537,934Columbia University Health Sciences · U01 · FY2001 · AI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies
$1,537,766William Douglas Figg · Division Of Clinical Sciences - Nci · ZIC · FY2022 · CA